Provided by Tiger Trade Technology Pte. Ltd.

OmniAb, Inc.

4.56
+0.21004.83%
Post-market: 4.560.00000.00%16:15 EDT
Volume:1.50M
Turnover:6.87M
Market Cap:660.21M
PE:-12.87
High:4.75
Open:4.35
Low:4.30
Close:4.35
52wk High:5.43
52wk Low:1.30
Shares:144.78M
Float Shares:107.31M
Volume Ratio:0.85
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3543
EPS(LYR):-0.5701
ROE:-16.95%
ROA:-8.35%
PB:2.54
PE(LYR):-8.00

Loading ...

OmniAb is Maintained at Buy by StoneX

Dow Jones
·
Yesterday

Leerink Partners Sticks to Its Buy Rating for OmniAb (OABI)

TIPRANKS
·
Yesterday

Stifel Nicolaus Sticks to Their Buy Rating for OmniAb (OABI)

TIPRANKS
·
Yesterday

OmniAb Inc : StoneX Raises Target Price to $6 from $4

THOMSON REUTERS
·
Yesterday

OmniAb Forecasts 2026 xPloration Revenue of $2 Million-$3 Million

Reuters
·
Oct 06

Corrected- OmniAb Outlook FY Xploration Revenue USD 2-3 Million (Adds Dropped Word 'Xploration', Removes Estimate)

THOMSON REUTERS
·
Oct 06

OmniAb Outlook FY Revenue USD 2-3 Million VS. Ibes Estimate USD 35.1 Million

THOMSON REUTERS
·
Oct 06

OmniAb to Host Investor & Analyst Day, Featuring Executive Presentations and xPloration Platform Demos

Reuters
·
Sep 14

OmniAb to Present at Nasdaq/LD Micro Summit Series

Reuters
·
Aug 26

Sector Update: Healthcare

MT Newswires Live
·
Aug 18

Top Midday Gainers

MT Newswires Live
·
Aug 18

OmniAb Price Target Maintained with a $11.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 18

U.S. Stocks on the MOVE - Sunrun, JetBlue Airways, Dell Technologies

Reuters
·
Aug 17

Analysts’ Opinions Are Mixed on These Healthcare Stocks: OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP)

TIPRANKS
·
Aug 17

H.C. Wainwright Keeps Their Buy Rating on OmniAb (OABI)

TIPRANKS
·
Aug 17

Nasdaq Opens Slightly Higher; Memory‑Related Stocks Broadly Higher, SanDisk up over 5%, SK Hynix up 4%; OABI Surges 19%

Tiger Newspress
·
Aug 17

U.S. Stocks on the MOVE - KBR, Vista Energy, Fulcrum Therapeutics

Reuters
·
Aug 17

Top Premarket Gainers

MT Newswires Live
·
Aug 17

Shares OmniAb Jump 36.3% Premarket on $370 Mln Drug Discovery Deal with Eli Lilly

THOMSON REUTERS
·
Aug 17

OmniAb Enters $370‑Million Drug‑Development Deal With Eli Lilly

Reuters
·
Aug 17